Showing results (561-570 of 610) with videos related to
Sort By:
Pageof 61
Nature Communications|January 3, 2026
Binimetinib and encorafenib for the treatment of advanced solid tumors with non-V600E BRAF mutations: results from the Phase II BEAVER trialApril A N Rose, Jennifer Maxwell, Emmanuelle Rousselle, et al.Immunity|February 9, 2022
Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunityKebria Hezaveh, Rahul S Shinde, Andreas Klötgen, et al.Genome Biology|August 11, 2010
Evolution of an adenocarcinoma in response to selection by targeted kinase inhibitorsSteven Jm Jones, Janessa Laskin, Yvonne Y Li, et al.Biorxiv : the Preprint Server for Biology|December 9, 2024
An updated reference genome sequence and annotation reveals gene losses and gains underlying naked mole-rat biologyDustin J Sokolowski, Mihai Miclăuş, Alexander Nater, et al.Cancer Research|March 17, 2019
Intratumoral Genetic and Functional Heterogeneity in Pediatric GlioblastomaMary Hoffman, Aaron H Gillmor, Daniel J Kunz, et al.Genome Medicine|October 27, 2016
Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trialTracy L Stockley, Amit M Oza, Hal K Berman, et al.Nature|June 29, 2017
Recurrent and functional regulatory mutations in breast cancerEsther Rheinbay, Prasanna Parasuraman, Jonna Grimsby, et al.European Journal of Human Genetics : EJHG|January 29, 2026
Non-invasive screening in hereditary cancer: a randomized controlled trial to test cell-free DNA-based early detection in the CHARM consortiumKirsten M Farncombe, Julia A Sobotka, Melyssa Aronson, et al.Journal for Immunotherapy of Cancer|March 15, 2019
An interim report on the investigator-initiated phase 2 study of pembrolizumab immunological response evaluation (INSPIRE)Derek L Clouthier, Scott C Lien, S Y Cindy Yang, et al.BMJ Open|October 22, 2020
Understanding and responding to COVID-19 in Wales: protocol for a privacy-protecting data platform for enhanced epidemiology and evaluation of interventionsJane Lyons, Ashley Akbari, Fatemeh Torabi, et al.Pageof 61